- Investing Ideas
- Swedish Biotech Breakthroughs
Swedish Biotech Breakthroughs
Results
7
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
7 companies
Ascelia Pharma
Market Cap: SEK 396.6m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.86
7D
-4.8%
1Y
-25.9%
Guard Therapeutics International
Market Cap: SEK 21.7m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.19
7D
12.1%
1Y
-91.5%
Lipigon Pharmaceuticals
Market Cap: SEK 2.4m
A clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.0036
7D
44.0%
1Y
-96.2%
Medivir
Market Cap: SEK 1.0b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.74
7D
-8.6%
1Y
0.1%
Vitrolife
Market Cap: SEK 14.5b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 107.90
7D
3.1%
1Y
-31.8%
BioInvent International
Market Cap: SEK 1.5b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 23.10
7D
5.2%
1Y
-29.1%
SynAct Pharma
Market Cap: SEK 842.3m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 13.94
7D
-20.7%
1Y
-25.9%